These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 17046183)
1. Mesoporous silica material TUD-1 as a drug delivery system. Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183 [TBL] [Abstract][Full Text] [Related]
2. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603 [TBL] [Abstract][Full Text] [Related]
3. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523 [TBL] [Abstract][Full Text] [Related]
5. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Yang YJ; Tao X; Hou Q; Chen JF Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
7. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery. Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793 [TBL] [Abstract][Full Text] [Related]
8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system. Yang P; Huang S; Kong D; Lin J; Fu H Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013 [TBL] [Abstract][Full Text] [Related]
9. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936 [TBL] [Abstract][Full Text] [Related]
10. Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route. Kang X; Huang S; Yang P; Ma P; Yang D; Lin J Dalton Trans; 2011 Mar; 40(9):1873-9. PubMed ID: 21183970 [TBL] [Abstract][Full Text] [Related]
11. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents. Sher P; Ingavle G; Ponrathnam S; Pawar AP Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470 [TBL] [Abstract][Full Text] [Related]
12. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236 [TBL] [Abstract][Full Text] [Related]
13. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428 [TBL] [Abstract][Full Text] [Related]
14. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour. Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160 [TBL] [Abstract][Full Text] [Related]
15. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials. Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849 [TBL] [Abstract][Full Text] [Related]
16. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Shen SC; Ng WK; Chia L; Hu J; Tan RB Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen. Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911 [No Abstract] [Full Text] [Related]
18. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery. Lin H; Zhu G; Xing J; Gao B; Qiu S Langmuir; 2009 Sep; 25(17):10159-64. PubMed ID: 19552374 [TBL] [Abstract][Full Text] [Related]
19. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. Kapoor S; Hegde R; Bhattacharyya AJ J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and in vitro pH-controllable drug release from mesoporous silica spheres with switchable gates. Gao Q; Xu Y; Wu D; Shen W; Deng F Langmuir; 2010 Nov; 26(22):17133-8. PubMed ID: 20939524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]